Phase
Condition
Aneurysm
Heart Disease
Cardiovascular Disease
Treatment
Endovascular aortic treatment
Clinical Study ID
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient has been treated/was intended to be treated with ZTA according to theclinical practice from Jan 2019 until site initiation
The patient is willing to participate in the study and provide written informedconsent for study participation or express non-objection or give written consent perlocal requirements prior to data collection of any data from medical records.
Exclusion
Exclusion Criteria:
A patient treated with a custom-made fenestrated and/or branched endovascular graftin conjunction with ZTA either during the same procedure or in a staged procedure.
A patient whose follow-up data collection is not possible (e.g. due to livingabroad).
Study Design
Study Description
Connect with a study center
CHU Dijon Bourgogne
Dijon, 21079
FranceActive - Recruiting
Hopital Marie Lannelongue Groupe Hospitalier Pairs St Joseph
Le Plessis-Robinson, 92350
FranceSite Not Available
Centre Hospitalier Regional Universitaire de Lille
Lille, 59000
FranceSite Not Available
Universitätsklinikum Hamburg-Eppendorf
Hamburg, 20246
GermanySite Not Available
Universitätsklinikum der LMU München
München, 81377
GermanySite Not Available
St. Franzikus Hospital Munster
Münster, 48145
GermanySite Not Available
IRCCS-University Hospital Sant'Orsolo Polyclinic
Bologna, 40138
ItalySite Not Available
IRCCS Ospedale San Raffaele
Milano, 20132
ItalySite Not Available
Maastricht University Medical Center
Maastricht, 6202 AZ
NetherlandsSite Not Available
Radboud UMC
Nijmegen, 6500 HB
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.